Previous Section Index Home Page

14 May 2007 : Column 611W—continued


14 May 2007 : Column 612W

The gross deficit is forecast to reduce in 2006-07 and building on the financial recovery in that year, the financial performance monitoring the SHAs and the Department have in place we expect the gross deficits to reduce further in 2007-08.

NHS: ICT

Anne Milton: To ask the Secretary of State for Health what the cost of implementing the NHS IT programme has been in (a) Surrey primary care trust and (b) England; what assessment her Department has made of the effectiveness of the implementation of the programme; and if she will make a statement. [127577]

Caroline Flint: I refer the hon. Lady to the reply given to my hon. Friend the Member for Birmingham, Sparkbrook and Small Heath (Mr. Godsiff) on 5 March 2007, Official Report, columns 1694-95W; and to those given to the hon. Member for North Norfolk (Norman Lamb) on 12 March 2007, Official Report, column 140W, and on 17 April 2007, Official Report, column 588W.

NHS: Procurement

Mr. Drew: To ask the Secretary of State for Health if she will assess the merits of placing controls on the ability of companies which supply drugs or equipment to the NHS to conduct direct lobbying with patients who receive that service. [128070]

Caroline Flint: There are already controls on companies that supply medicines to the national health service. The Medicines (Advertising) Regulations 1994 prohibit the advertising of prescription only medicines to the public. Any promotion of a prescription only medicine to patients including lobbying activity that may lead to them seeking a prescription from their healthcare provider is likely to fall within this prohibition. Companies may provide non-promotional information, provided they do not promote a specific prescription only medicine.

Products which are defined as medical devices are regulated under the Medical Devices Regulations 2002. The regulations do not cover direct lobbying activities by manufacturers who place medical devices on the market. However, such activities can be dealt with under the Trade Descriptions Act 1968 or the Control of Misleading Advertising Regulations l998.

NHS: Public Appointments

Keith Vaz: To ask the Secretary of State for Health which body is responsible for setting the criteria for appointments made by the Appointments Commission. [135966]

Ms Rosie Winterton: The Department agrees the criteria for national health service appointments made by the Appointments Commission.

Keith Vaz: To ask the Secretary of State for Health what targets on diversity have been set for the appointments made by the Appointments Commission. [135967]


14 May 2007 : Column 613W

Ms Rosie Winterton: Targets for representation in local national health service appointments are for 50 per cent. of those appointed to be women, 10 per cent. to be from black and minority ethnic groups and 6 per cent. of those appointed to be disabled.

NHS: Standards

Mr. Nicholas Brown: To ask the Secretary of State for Health what assessment she has made of the effectiveness of the National Service Framework for (a) cancer, (b) children, (c) chronic obstructive pulmonary disease, (d) coronary heart disease, (e) diabetes, (f) long-term conditions, (g) mental health, (h) older people and (i) renal services in raising standards of care offered to patients. [135909]

Ms Rosie Winterton: The Department has published a number of progress reports looking at the impact of the national service frameworks (NSFs). These are detailed below and are available in the Library:

NHS: Training

Helen Jones: To ask the Secretary of State for Health what steps she is taking to ensure that all health authorities and trusts produce integrated plans for learning and service development as recommended in the recent report by Professor Fryer. [123833]

Ms Rosie Winterton [holding answer 27 February 2007]: The Department is currently assessing the responses to “Learning for a Change in Healthcare” and expects to be in a position to propose the next steps for implementation of its recommendations by July 2007. The Department has also already ensured that the service level agreement with the strategic health authorities (SHAs) provides a commitment to

It also sets a key performance indicator, requiring a

Obesity

Mr. Lansley: To ask the Secretary of State for Health what the rates of obesity amongst adults were in the most recent period for which figures are available, broken down by primary care trust area. [131906]

Caroline Flint: Estimates of prevalence of obesity among adults based on 2000-02 data are presented by primary care organisation (PCO) and this information has been placed in the Library. Primary care organisations represent both primary care trusts, and care trusts.

These estimates represent the prevalence of obesity for any PCO based on population characteristics of that area, together with a statistical model linking population characteristics and obesity levels. The estimates have been generated using a model-based method that combined individual-level data from the Health Survey for England (HSfE) with area-level measures from the 2001 census and from administrative datasets.

The methodology used to produce these estimates is relatively new and as a result may be subject to consultation, modification and further development. In view of this ongoing work the estimates have been published as experimental statistics.


14 May 2007 : Column 615W

Confidence intervals have been produced to accompany the model-based estimates in order to make the accuracy of the estimates clear. It is important to take into account the variability in the estimates when interpreting them. Therefore, the expected prevalence for a PCO should be viewed in light of its confidence interval rather than just the expected obesity prevalence estimate.

As these are estimates only, we discourage any ranking of the data. The table indicates how the estimated prevalence of each PCO compares with the national estimate for obesity prevalence.

Mr. Ruffley: To ask the Secretary of State for Health what percentage of (a) children and (b) adults are (i) obese and (ii) overweight when measured by body mass index according to the Government's most recent health survey figures in (A) Bury St. Edmunds constituency, (B) Suffolk County Council area, (C) the East of England and (D) England. [134664]

Caroline Flint: The information is not available in the format requested. Data on overweight and obesity prevalence are available from the Health Survey for England (HSE).

Data on the proportion of men and women who are overweight and obese are available from the HSE 2005. Data on the proportion of men and women who are overweight and obese in the East of England Government Office Region (GOR) has been taken from the HSE 2003, as this year included a sample boost. Data on overweight and obesity prevalence for Suffolk county council are not available. However data for the Norfolk, Suffolk and Cambridgeshire Strategic Health Authority for adults are given and combined for the years 2002 to 2004 due to small sample sizes. Information for Bury St. Edmunds constituency's overweight and obesity prevalence is not available. However, estimated overweight and obesity information is given for Suffolk West Primary Care Trust (PCT) in which Bury St. Edmunds falls.

Data for children's overweight and obesity prevalence in England are available from the 2005 HSE. Data for children's overweight and obesity prevalence in the East of England GOR have been combined for the years 2002 to 2004, due to small sample sizes. Information for children's overweight and obesity prevalence is not available below a regional level.

Table 1 shows the proportion of men and women who are overweight and obese in England, in 2005.

Table 2 shows the proportion of men and women who are overweight and obese in the East of England GOR, in 2003.

Table 3 shows the proportion of men and women who are overweight and obese in the Norfolk, Suffolk and Cambridgeshire Strategic Health Authority, in 2002-2004 combined.

Table 4 shows estimates of the prevalence of adults who are obese in Suffolk West PCT, 2000-2002

Table 5 shows the proportion of boys and girls aged two to 15 who are overweight and obese in England, in 2005.

Table 6 shows the proportion of boys and girls aged two to 15 who are overweight and obese in the East of England GOR, in 2002-2004 combined.

All the tables have been placed in the Library.


14 May 2007 : Column 616W

Mr. Lansley: To ask the Secretary of State for Health how many people were treated for obesity by the NHS in each year since 1997, broken down by the treatment they received; and what the cost was of providing each treatment in the latest period for which figures are available. [135766]

Caroline Flint: Hospital activity and cost information relating to obesity is presented as follows. Figures have been provided on the number of finished consultant episodes (FCEs) with a primary and secondary diagnosis of obesity. Information is also provided on drugs prescribed for the treatment of obesity, including the costs of such drugs. Costs relating specifically to treatment costs for obesity are not available.

Table 1 shows the number of FCEs with a primary and secondary diagnosis of obesity, for the years 1996-97 to 2005-06.

Table 2 shows the number of items, net ingredient cost and the average net ingredient cost per item of drugs for the treatment of obesity prescribed in England and dispensed in the community, for the years 2002 to 2006.

Table 1: Finished consultant episodes( 1) , by primary or secondary diagnosis( 2) of obesity, 1996-97 to 2005-06( 3) , England
Number
Primary diagnosis Secondary diagnosis

1996-97

787

21,257

1997-98

781

22,320

1998-99

1,049

23,633

1999-2000

1,073

24,480

2000-01

1,170

25,947

2001-02

1,121

27,349

2002-03

1,406

34,701

2003-04

1,856

40,060

2004-05

2,185

49,187

2005-06

2,749

62,708

(1) An FCE is defined as a period of admitted patient care under one consultant within one health care provider.
(2) ICD-10 code E66 has been used as a diagnosis for obesity.
(3) Figures have not been adjusted for shortfalls in data.
Source:
Hospital Episode Statistics, HES. The Information Centre.


14 May 2007 : Column 617W
Table 2: Number of items, net ingredient cost and average net ingredient cost per item of drugs for the treatment of obesity prescribed( 1) in England and dispensed in the community, 2002 to 2006, England
2002 2003 2004 2005 2006

Prescription Items (Thousand)

Orlistat

540

484

492

645

774

Sibutramine

196

203

208

226

263

Total(2)

737

688

699

871

1,060

Net Ingredient Cost (£000)

Orlistat

23,401

21,036

21,391

27,020

32,476

Sibutramine

7,752

8,458

9,314

10,984

13,654

Total(2)

31,203

29,532

30,706

38,004

47,541

Net Ingredient Cost per item (£)

Orlistat

43

43

44

42

42

Sibutramine

39

42

45

49

52

Total(2)

42

43

44

44

45

(1) Includes prescriptions prescribed by GPs, nurses, pharmacists and others in England and dispensed in the community in the UK. Prescriptions written in hospitals/clinics that are dispensed in the community, prescriptions dispensed in hospitals and private prescriptions are not included in PACT data.
(2) Includes ‘other’ drugs for the treatment if obesity which include Mazindol, Rimonabant, Phentermine and Diethylpropion Hydrochloride.
Source:
Prescribing Analyses and Cost (PACT) from the Prescription Pricing Division of the Business Services Authority (PPD of the BSA).

Next Section Index Home Page